Symbols / PRFX $2.70 +28.33% PRF Technologies Ltd.
PRFX Chart
About
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 2.28M |
| Enterprise Value | -1.60M | Income | -4.84M | Sales | 17.00K |
| Book/sh | 10.29 | Cash/sh | 4.90 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | 0.02 | Forward P/E | -0.22 | PEG | — |
| P/S | 133.89 | P/B | 0.26 | P/C | — |
| EV/EBITDA | 0.37 | EV/Sales | -94.11 | Quick Ratio | 1.75 |
| Current Ratio | 1.78 | Debt/Eq | 0.23 | LT Debt/Eq | — |
| EPS (ttm) | -7.43 | EPS next Y | -12.06 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-08-15 16:00 | ROA | -38.75% |
| ROE | -90.37% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -162.00% | Profit Margin | 0.00% | Shs Outstand | 844.55K |
| Shs Float | 805.82K | Short Float | 9.74% | Short Ratio | 1.37 |
| Short Interest | — | 52W High | 17.95 | 52W Low | 1.80 |
| Beta | 0.71 | Avg Volume | 541.73K | Volume | 24.49M |
| Target Price | — | Recom | None | Prev Close | $2.10 |
| Price | $2.69 | Change | 28.33% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.69
Latest analyst target
3. DCF / Fair value
$-42.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.69
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-10-24 | down | Maxim Group | Buy → Hold | — |
| 2024-06-26 | reit | Maxim Group | Buy → Buy | $2 |
- PRFX Approaches Its 20-Day Peak—Will It Achieve a Genuine Breakout? - Bitget Mon, 06 Apr 2026 11
- PRFX SEC Filings - PRF Technologies Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan Sat, 04 Apr 2026 07
- PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push - Benzinga Fri, 16 Jan 2026 08
- PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI Sat, 04 Apr 2026 15
- PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot - theglobeandmail.com Sat, 28 Mar 2026 14
- PRFX Should I Buy - Intellectia AI ue, 31 Mar 2026 21
- Drop-less cataract therapy and solar AI now drive PRF's 2025 pivot - Stock Titan Fri, 27 Mar 2026 12
- AI solar platform DeepSolar taps Blade Ranger to chase 150MW+ deals - Stock Titan ue, 17 Mar 2026 07
- PRF Technologies (PRFX) director holds 3,000 employee stock options - Stock Titan Wed, 18 Mar 2026 07
- Director at PRF Technologies (PRFX) discloses stock option holdings - Stock Titan Wed, 18 Mar 2026 07
- Director Augustine Lawlor details option holdings in PRF Technologies (PRFX) - Stock Titan Wed, 18 Mar 2026 07
- AI system to monitor 71 MW Romanian solar farm in new PRF deal - Stock Titan Wed, 11 Feb 2026 08
- PRF Technologies (PRFX) COO lists vested and future option rights - Stock Titan Wed, 18 Mar 2026 07
- [6-K] PRF Technologies Ltd. Current Report (Foreign Issuer) | PRFX SEC Filing - Form 6-K - Stock Titan Fri, 27 Mar 2026 07
- PRF Technologies (PRFX) interim CEO lists stock option holdings - Stock Titan Wed, 18 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.02
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.02
|
0.00
|
0.00
|
0.00
|
| Cost Of Revenue |
|
0.07
|
0.00
|
0.00
|
—
|
| Reconciled Cost Of Revenue |
|
0.06
|
0.00
|
0.00
|
—
|
| Gross Profit |
|
-0.05
|
0.00
|
0.00
|
—
|
| Operating Expense |
|
5.07
-65.45%
|
14.67
+53.10%
|
9.58
+8.06%
|
8.87
|
| Research And Development |
|
1.14
-90.29%
|
11.71
+93.95%
|
6.04
+36.48%
|
4.42
|
| Selling General And Administration |
|
3.17
+6.94%
|
2.97
-16.37%
|
3.55
-20.19%
|
4.45
|
| Selling And Marketing Expense |
|
0.16
|
0.00
|
0.00
|
—
|
| General And Administrative Expense |
|
3.01
+1.45%
|
2.97
-16.37%
|
3.55
-20.19%
|
4.45
|
| Salaries And Wages |
|
1.12
+7.18%
|
1.04
-35.01%
|
1.61
-14.65%
|
1.88
|
| Other Gand A |
|
1.54
+1.92%
|
1.51
+11.65%
|
1.36
-18.36%
|
1.66
|
| Total Expenses |
|
5.14
-64.98%
|
14.67
+53.10%
|
9.58
+8.06%
|
8.87
|
| Operating Income |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| Total Operating Income As Reported |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| EBITDA |
|
-4.35
+70.33%
|
-14.66
-53.17%
|
-9.57
-8.08%
|
-8.85
|
| Normalized EBITDA |
|
-4.35
+70.36%
|
-14.66
-29.80%
|
-11.30
-28.48%
|
-8.79
|
| Reconciled Depreciation |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| EBIT |
|
-5.12
+65.09%
|
-14.67
-53.10%
|
-9.58
-8.06%
|
-8.87
|
| Total Unusual Items |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Total Unusual Items Excluding Goodwill |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Net Income |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Pretax Income |
|
-5.01
+65.61%
|
-14.58
-56.17%
|
-9.34
-6.30%
|
-8.78
|
| Net Non Operating Interest Income Expense |
|
0.11
+26.44%
|
0.09
+105.88%
|
-1.48
-1106.80%
|
0.15
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
0.00
|
| Net Interest Income |
|
0.11
+26.44%
|
0.09
+105.88%
|
-1.48
-1106.80%
|
0.15
|
| Interest Expense |
|
—
|
—
|
—
|
0.00
|
| Interest Income Non Operating |
|
0.12
+18.81%
|
0.10
-75.12%
|
0.41
+153.75%
|
0.16
|
| Interest Income |
|
0.12
+18.81%
|
0.10
-75.12%
|
0.41
+153.75%
|
0.16
|
| Other Income Expense |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Gain On Sale Of Security |
|
-0.00
-133.33%
|
0.01
-99.65%
|
1.73
+2932.79%
|
-0.06
|
| Tax Provision |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
-11.11%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
-133.33%
|
0.00
-99.65%
|
0.40
+2932.79%
|
-0.01
|
| Net Income Including Noncontrolling Interests |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income From Continuing Operation Net Minority Interest |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income From Continuing And Discontinued Operation |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Net Income Continuous Operations |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Normalized Income |
|
-5.02
+65.60%
|
-14.59
-36.70%
|
-10.67
-22.06%
|
-8.75
|
| Net Income Common Stockholders |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Diluted EPS |
|
—
|
-105.52
+14.17%
|
-122.94
+61.25%
|
-317.30
|
| Basic EPS |
|
—
|
-105.52
+14.17%
|
-122.94
+61.25%
|
-317.30
|
| Basic Average Shares |
|
—
|
0.14
+81.90%
|
0.08
+174.30%
|
0.03
|
| Diluted Average Shares |
|
—
|
0.14
+81.90%
|
0.08
+174.30%
|
0.03
|
| Diluted NI Availto Com Stockholders |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Amortization |
|
0.76
|
—
|
—
|
—
|
| Amortization Of Intangibles Income Statement |
|
0.76
|
—
|
—
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
0.76
|
—
|
—
|
—
|
| Depreciation And Amortization In Income Statement |
|
0.76
|
—
|
—
|
—
|
| Insurance And Claims |
|
0.17
-36.12%
|
0.26
-33.25%
|
0.39
-39.66%
|
0.65
|
| Rent And Landing Fees |
|
0.18
+23.29%
|
0.15
-23.56%
|
0.19
-23.29%
|
0.25
|
| Rent Expense Supplemental |
|
0.18
+23.29%
|
0.15
-23.56%
|
0.19
-23.29%
|
0.25
|
| Total Other Finance Cost |
|
0.01
-28.57%
|
0.01
-99.26%
|
1.89
+14407.69%
|
0.01
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
9.93
|
| Current Assets |
|
9.80
|
| Cash Cash Equivalents And Short Term Investments |
|
8.03
|
| Cash And Cash Equivalents |
|
8.03
|
| Other Short Term Investments |
|
0.00
|
| Receivables |
|
0.04
|
| Other Receivables |
|
0.04
|
| Prepaid Assets |
|
1.72
|
| Restricted Cash |
|
0.01
|
| Other Current Assets |
|
—
|
| Total Non Current Assets |
|
0.13
|
| Net PPE |
|
0.13
|
| Gross PPE |
|
0.13
|
| Properties |
|
0.00
|
| Buildings And Improvements |
|
0.09
|
| Other Properties |
|
0.04
|
| Goodwill And Other Intangible Assets |
|
—
|
| Goodwill |
|
—
|
| Other Intangible Assets |
|
—
|
| Total Liabilities Net Minority Interest |
|
2.69
|
| Current Liabilities |
|
2.41
|
| Payables And Accrued Expenses |
|
1.89
|
| Payables |
|
0.22
|
| Accounts Payable |
|
0.22
|
| Current Accrued Expenses |
|
1.67
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.47
|
| Current Debt And Capital Lease Obligation |
|
0.06
|
| Current Capital Lease Obligation |
|
0.06
|
| Total Non Current Liabilities Net Minority Interest |
|
0.28
|
| Long Term Debt And Capital Lease Obligation |
|
0.03
|
| Long Term Capital Lease Obligation |
|
0.03
|
| Non Current Deferred Liabilities |
|
0.25
|
| Non Current Deferred Taxes Liabilities |
|
0.25
|
| Stockholders Equity |
|
7.24
|
| Common Stock Equity |
|
7.24
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
0.01
|
| Ordinary Shares Number |
|
0.01
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
49.10
|
| Retained Earnings |
|
-41.86
|
| Minority Interest |
|
—
|
| Total Equity Gross Minority Interest |
|
7.24
|
| Total Capitalization |
|
7.24
|
| Working Capital |
|
7.39
|
| Invested Capital |
|
7.24
|
| Total Debt |
|
0.09
|
| Capital Lease Obligations |
|
0.09
|
| Net Tangible Assets |
|
7.24
|
| Tangible Book Value |
|
7.24
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3.96
+68.66%
|
-12.62
-88.97%
|
-6.68
-3.41%
|
-6.46
|
| Cash Flow From Continuing Operating Activities |
|
-3.96
+68.66%
|
-12.62
-88.97%
|
-6.68
-3.41%
|
-6.46
|
| Net Income From Continuing Operations |
|
-5.02
+65.57%
|
-14.59
-56.12%
|
-9.34
-6.28%
|
-8.79
|
| Depreciation Amortization Depletion |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Depreciation |
|
0.01
-6.25%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Amortization Cash Flow |
|
0.76
|
—
|
—
|
—
|
| Depreciation And Amortization |
|
0.77
+4737.50%
|
0.02
+6.67%
|
0.01
+0.00%
|
0.01
|
| Amortization Of Intangibles |
|
0.76
|
—
|
—
|
—
|
| Other Non Cash Items |
|
-0.00
+60.00%
|
-0.01
-100.63%
|
1.58
+514.01%
|
0.26
|
| Stock Based Compensation |
|
0.45
+44.19%
|
0.31
-61.44%
|
0.80
-42.12%
|
1.39
|
| Operating Gains Losses |
|
0.00
+133.33%
|
-0.01
+99.56%
|
-1.36
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-1.36
|
—
|
| Net Foreign Currency Exchange Gain Loss |
|
0.00
+133.33%
|
-0.01
-200.00%
|
-0.00
|
0.00
|
| Change In Working Capital |
|
-0.15
-109.17%
|
1.66
+1.78%
|
1.63
+142.26%
|
0.67
|
| Change In Prepaid Assets |
|
-0.02
-101.37%
|
1.60
+386.36%
|
0.33
-7.30%
|
0.36
|
| Change In Payables And Accrued Expense |
|
-0.13
-350.00%
|
0.05
-95.99%
|
1.30
+310.76%
|
0.32
|
| Change In Accrued Expense |
|
0.11
+570.83%
|
-0.02
-101.87%
|
1.29
+429.22%
|
0.24
|
| Change In Payable |
|
-0.24
-419.74%
|
0.08
+533.33%
|
0.01
-83.56%
|
0.07
|
| Change In Account Payable |
|
-0.24
-419.74%
|
0.08
+533.33%
|
0.01
-83.56%
|
0.07
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Investing Cash Flow |
|
-0.98
-7453.85%
|
-0.01
-100.22%
|
5.99
+199.75%
|
-6.01
|
| Cash Flow From Continuing Investing Activities |
|
-0.98
-7453.85%
|
-0.01
-100.22%
|
5.99
+199.75%
|
-6.01
|
| Net PPE Purchase And Sale |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Purchase Of PPE |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Capital Expenditure |
|
-0.00
+84.62%
|
-0.01
-44.44%
|
-0.01
-50.00%
|
-0.01
|
| Net Investment Purchase And Sale |
|
-1.00
|
0.00
-100.00%
|
6.00
+200.00%
|
-6.00
|
| Purchase Of Investment |
|
-1.00
|
0.00
+100.00%
|
-1.00
+83.33%
|
-6.00
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
7.00
|
—
|
| Net Business Purchase And Sale |
|
0.02
|
—
|
—
|
—
|
| Financing Cash Flow |
|
3.82
-56.92%
|
8.86
+92.01%
|
4.62
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
3.82
-56.92%
|
8.86
+92.01%
|
4.62
|
0.00
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
—
|
—
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Net Common Stock Issuance |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
4.75
+23.49%
|
3.85
|
0.00
|
| Net Other Financing Charges |
|
-0.19
+84.62%
|
-1.24
-32.51%
|
-0.93
|
—
|
| Changes In Cash |
|
-1.12
+70.33%
|
-3.77
-196.00%
|
3.93
+131.51%
|
-12.46
|
| Effect Of Exchange Rate Changes |
|
-0.00
-133.33%
|
0.01
+200.00%
|
0.00
|
0.00
|
| Beginning Cash Position |
|
4.27
-46.85%
|
8.04
+95.71%
|
4.11
-75.22%
|
16.57
|
| End Cash Position |
|
3.15
-26.25%
|
4.27
-46.85%
|
8.04
+95.71%
|
4.11
|
| Free Cash Flow |
|
-3.96
+68.68%
|
-12.63
-88.91%
|
-6.69
-3.45%
|
-6.46
|
| Common Stock Issuance |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Issuance Of Capital Stock |
|
4.01
-25.08%
|
5.35
+214.15%
|
1.70
|
0.00
|
| Sale Of Business |
|
0.02
|
—
|
—
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|